Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001017062-02-002032
Filing Date
2002-11-25
Accepted
2002-11-25 10:35:35
Documents
1
Period of Report
2002-11-27
Effectiveness Date
2002-11-25

Document Format Files

Seq Description Document Type Size
1 DEFININITVE INFORMATION STATEMENT ddef14c.htm DEF 14C 541192
  Complete submission text file 0001017062-02-002032.txt   542790
Mailing Address 9 PARKER IRVINE CA 92618
Business Address 9 PARKER IRVINE CA 92618 9494709011
NEXELL THERAPEUTICS INC (Filer) CIK: 0000864009 (see all company filings)

EIN.: 061192468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-19153 | Film No.: 02838786
SIC: 2834 Pharmaceutical Preparations